Literature DB >> 11079612

Lipid profile in patients with fibromyalgia and myofascial pain syndromes.

S Ozgocmen1, O Ardicoglu.   

Abstract

In this study serum lipid profile of patients with fibromyalgia syndrome (FMS) and myofascial pain syndrome (MPS) were investigated and compared with healthy controls. Thirty women who had FMS and 32 women who had MPS with the characteristic trigger points (TrP), especially on the periscapular region were included in this study. Thirty one age matched healthy women were assigned as a control group. All of the subjects were sedentary healthy housewives. Total cholesterol, triglyceride and high-density lipoprotein cholesterol (HDL-c) levels were not significantly different between the FMS and control groups. On the other hand the MPS group had total cholesterol (198.7 vs 172.9 mg/dL, p=0.003), triglyceride (124.7 vs 87.6 mg/dL, p=0.01), low-density lipoprotein cholesterol (LDL-c) (127.5 vs 108.4 mg/dL, p=0.02) and very low-density lipoprotein cholesterol (VLDL-c) (24.9 vs 17.3 mg/dL, p=0.008) levels, which were significantly higher than the controls. There was no significant difference between the lipid profiles in the FMS and MPS groups. Tissue compliance, which was measured from trigger points in the MPS group, correlated significantly with total cholesterol and LDL-c levels. In conclusion, a significant difference was found between the lipid levels of patients with MPS and the controls. More extensive investigation of lipid and lipoprotein levels is required to determine whether high lipid levels are the cause or result of MPS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079612     DOI: 10.3349/ymj.2000.41.5.541

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  5 in total

1.  Serum lipid profile in fibromyalgia women.

Authors:  Gulcan Gurer; Omer Faruk Sendur; Cavidan Ay
Journal:  Clin Rheumatol       Date:  2005-10-01       Impact factor: 2.980

2.  Clinical symptoms in fibromyalgia are associated to overweight and lipid profile.

Authors:  Mario D Cordero; Elísabet Alcocer-Gómez; Francisco J Cano-García; Benito Sánchez-Domínguez; Patricia Fernández-Riejo; Ana M Moreno Fernández; Ana Fernández-Rodríguez; Manuel De Miguel
Journal:  Rheumatol Int       Date:  2013-01-03       Impact factor: 2.631

3.  Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.

Authors:  A Kamanli; A Kaya; O Ardicoglu; S Ozgocmen; F Ozkurt Zengin; Y Bayik
Journal:  Rheumatol Int       Date:  2004-09-15       Impact factor: 2.631

4.  Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation.

Authors:  Takako Miyamae; Manabu Seki; Tomoko Naga; Shinya Uchino; Haruki Asazuma; Takuma Yoshida; Yuki Iizuka; Masako Kikuchi; Tomoyuki Imagawa; Yutaka Natsumeda; Shumpei Yokota; Yorihiro Yamamoto
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

5.  Systemic differences in serum metabolome: a cross sectional comparison of women with localised and widespread pain and controls.

Authors:  J Hadrévi; M Björklund; E Kosek; S Hällgren; H Antti; M Fahlström; F Hellström
Journal:  Sci Rep       Date:  2015-11-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.